Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Medical Genetics
Published in: BMC Medical Genetics 1/2008

Open Access 01-12-2008 | Research article

The APOA5Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides

Authors: Jean Dallongeville, Dominique Cottel, Aline Wagner, Pierre Ducimetière, Jean-Bernard Ruidavets, Dominique Arveiler, Annie Bingham, Jean Ferrières, Philippe Amouyel, Aline Meirhaeghe

Published in: BMC Medical Genetics | Issue 1/2008

Login to get access

Abstract

Background

The goal of the present study was to assess the effect of genetic variability at the APOA5/A4/C3/A1 cluster locus on the risk of metabolic syndrome.

Methods

The APOA5 Ser19Trp, APOA5 -12,238T>C, APOA4 Thr347Ser, APOC3 -482C>T and APOC3 3238C>G (SstI) polymorphisms were analyzed in a representative population sample of 3138 men and women from France, including 932 individuals with metabolic syndrome and 2206 without metabolic syndrome, as defined by the NCEP criteria.

Results

Compared with homozygotes for the common allele, the odds ratio (OR) [95% CI] for metabolic syndrome was 1.30 [1.03–1.66] (p = 0.03) for APOA5 Trp19 carriers, 0.81 [0.69–0.95] (p = 0.01) for APOA5 -12,238C carriers and 0.84 [0.70–0.99] (p = 0.04) for APOA4 Ser347 carriers. Adjustment for plasma triglycerides, (but not for waist girth, HDL, blood pressure or glycemia – the other components of metabolic syndrome) abolished these associations and suggests that triglyceride levels explain the association with metabolic syndrome. There was no association between the APOC3 -482C>T or APOC3 3238C>G polymorphisms and metabolic syndrome. The decreased risk of metabolic syndrome observed in APOA5 -12,238C and APOA4 Ser347 carriers merely reflected the fact that the APOA5 Trp19 allele was in negative linkage disequilibrium with the common alleles of APOA5 -12,238T>C and APOA4 Thr347Ser polymorphisms.

Conclusion

The APOA5 Trp19 allele increased susceptibility to metabolic syndrome via its impact on plasma triglyceride levels.
Literature
1.
Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607. 10.2337/diabetes.37.12.1595.CrossRefPubMed
2.
Timar O, Sestier F, Levy E: Metabolic syndrome X: A review. Can J Cardiol. 2000, 16: 779-789.PubMed
3.
Mitchell BD, Kammerer CM, Mahaney MC, Blangero J, Comuzzie AG, Atwood LD, Haffner SM, Stern MP, MacCluer JW: Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol. 1996, 16: 281-288.CrossRefPubMed
4.
Hong Y, Pedersen NL, Brismar K, de Faire U: Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet. 1997, 60: 143-152.PubMedPubMedCentral
5.
Chen W, Srinivasan SR, Elkasabany A, Berenson GS: The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. Atherosclerosis. 1999, 145: 197-205. 10.1016/S0021-9150(99)00025-8.CrossRefPubMed
6.
Dallongeville J, Helbecque N, Cottel D, Amouyel P, Meirhaeghe A: The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab. 2003, 88: 4862-4866. 10.1210/jc.2003-030173.CrossRefPubMed
7.
Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J: Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women. Diabetes. 2005, 54: 3043-3048. 10.2337/diabetes.54.10.3043.CrossRefPubMed
8.
Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Segawa T, Watanabe S, Ichihara S, Yoshida H, Satoh K, Nozawa Y: Prediction of genetic risk for metabolic syndrome. Atherosclerosis. 2007, 191: 298-304. 10.1016/j.atherosclerosis.2006.05.035.CrossRefPubMed
9.
Yamada Y, Ichihara S, Kato K, Yoshida T, Yokoi K, Matsuo H, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Lee W, Nozawa Y: Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet. 2008, 45: 22-28. 10.1136/jmg.2007.052415.CrossRefPubMed
10.
Grallert H, Sedlmeier EM, Huth C, Kolz M, Heid IM, Meisinger C, Herder C, Strassburger K, Gehringer A, Haak M, Giani G, Kronenberg F, Wichmann HE, Adamski J, Paulweber B, Illig T, Rathmann W: APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res. 2007, 48: 2614-2621. 10.1194/jlr.M700011-JLR200.CrossRefPubMed
11.
Kisfali P, Mohas M, Maasz A, Hadarits F, Marko L, Horvatovich K, Oroszlan T, Bagosi Z, Bujtor Z, Gasztonyi B, Wittmann I, Melegh B: Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians. Circ J. 2008, 72: 40-43. 10.1253/circj.72.40.CrossRefPubMed
12.
Maasz A, Kisfali P, Horvatovich K, Mohas M, Marko L, Csongei V, Farago B, Jaromi L, Magyari L, Safrany E, Sipeky C, Wittmann I, Melegh B: Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathol Oncol Res. 2007, 13: 243-247.CrossRefPubMed
13.
Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001, 294: 169-173. 10.1126/science.1064852.CrossRefPubMed
14.
Baroukh N, Bauge E, Akiyama J, Chang J, Afzal V, Fruchart JC, Rubin EM, Fruchart-Najib J, Pennacchio LA: Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice. Arterioscler Thromb Vasc Biol. 2004, 24: 1297-1302. 10.1161/01.ATV.0000130463.68272.1d.CrossRefPubMed
15.
Fruchart-Najib J, Bauge E, Niculescu LS, Pham T, Thomas B, Rommens C, Majd Z, Brewer B, Pennacchio LA, Fruchart JC: Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun. 2004, 319: 397-404. 10.1016/j.bbrc.2004.05.003.CrossRefPubMed
16.
Schaap FG, Rensen PC, Voshol PJ, Vrins C, Vliet van der HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW: ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem. 2004, 279: 27941-27947. 10.1074/jbc.M403240200.CrossRefPubMed
17.
van Dijk KW, Rensen PC, Voshol PJ, Havekes LM: The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?. Curr Opin Lipidol. 2004, 15: 239-246. 10.1097/00041433-200406000-00002.CrossRefPubMed
18.
Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J: Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem. 2005, 280: 21553-21560. 10.1074/jbc.M411412200.CrossRefPubMed
19.
Nowak M, Helleboid-Chapman A, Jakel H, Martin G, Duran-Sandoval D, Staels B, Rubin EM, Pennacchio LA, Taskinen MR, Fruchart-Najib J, Fruchart JC: Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor. Mol Cell Biol. 2005, 25: 1537-1548. 10.1128/MCB.25.4.1537-1548.2005.CrossRefPubMedPubMedCentral
20.
Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC: Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2002, 11: 3031-3038. 10.1093/hmg/11.24.3031.CrossRefPubMed
21.
Hubacek JA: Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin Chem Lab Med. 2005, 43: 897-902. 10.1515/CCLM.2005.153.CrossRefPubMed
22.
Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, Joglekar CV, Fall CH, Mohankrishna P, Wilkin TJ, Metcalf BS, Weedon MN, Frayling TM, Hattersley AT: Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. BMC Med Genet. 2006, 7: 76-10.1186/1471-2350-7-76.CrossRefPubMedPubMedCentral
23.
Lai CQ, Parnell LD, Ordovas JM: The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol. 2005, 16: 153-166. 10.1097/01.mol.0000162320.54795.68.CrossRefPubMed
24.
Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE: Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002, 11: 3039-3046. 10.1093/hmg/11.24.3039.CrossRefPubMed
25.
The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988, 41: 105-114. 10.1016/0895-4356(88)90084-4.
26.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev. 2005, 13: 322-327.PubMed
27.
Alberti KG, Zimmet P, Shaw J: The metabolic syndrome – a new worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
28.
Miltiadous G, Hatzivassiliou M, Bashiardes E, Bairaktari E, Cariolou MA, Elisaf M: Genetic polymorphisms of the apolipoprotein A-IV in a Greek population and their relation to plasma lipid and lipoprotein levels. Clin Genet. 2002, 62: 208-213. 10.1034/j.1399-0004.2002.620304.x.CrossRefPubMed
29.
Slatkin M, Excoffier L: Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity. 1996, 76: 377-383. 10.1038/hdy.1996.55.CrossRefPubMed
30.
Lewontin RC: The interaction of selection and linkage. I. General considerations; heterotic models. Genetics. 1964, 49: 49-67.PubMedPubMedCentral
31.
Tregouet DA, Barbaux S, Escolano S, Tahri N, Golmard JL, Tiret L, Cambien F: Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet. 2002, 11: 2015-2023. 10.1093/hmg/11.17.2015.CrossRefPubMed
32.
Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL: A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet. 2004, 68: 165-177. 10.1046/j.1529-8817.2003.00085.x.CrossRefPubMed
33.
de Koning L, Merchant AT, Pogue J, Anand SS: Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007, 28: 850-856. 10.1093/eurheartj/ehm026.CrossRefPubMed
34.
Kusterer K, Pohl T, Fortmeyer HP, Marz W, Scharnagl H, Oldenburg A, Angermuller S, Fleming I, Usadel KH, Busse R: Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats. Cardiovasc Res. 1999, 42: 783-793. 10.1016/S0008-6363(98)00331-9.CrossRefPubMed
Metadata
Title
The APOA5Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides
Authors
Jean Dallongeville
Dominique Cottel
Aline Wagner
Pierre Ducimetière
Jean-Bernard Ruidavets
Dominique Arveiler
Annie Bingham
Jean Ferrières
Philippe Amouyel
Aline Meirhaeghe
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2008
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-9-84

Other articles of this Issue 1/2008

BMC Medical Genetics 1/2008 Go to the issue

Research article

A novel WFS1 mutation in a family with dominant low frequency sensorineural hearing loss with normal VEMP and EcochG findings

Research article

Diabetes-specific genetic effects on obesity traits in American Indian populations: the Strong Heart Family Study

Research article

Identification of a novel KCNQ1 mutation associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long QT syndrome in a Chinese family

Research article

Polymorphisms of selected Xenobiotic Genes contribute to the development of Papillary Thyroid Cancer susceptibility in Middle Eastern population

Research article

Autosomal dominant hereditary spastic paraplegia: Novel mutations in the REEP1 gene (SPG31)

Research article

N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico study